Logo image of KIDS

ORTHOPEDIATRICS CORP (KIDS) Stock Fundamental Analysis

USA - NASDAQ:KIDS - US68752L1008 - Common Stock

16.3 USD
-1.65 (-9.19%)
Last: 10/10/2025, 8:39:59 PM
15.52 USD
-0.78 (-4.79%)
After Hours: 10/10/2025, 8:39:59 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to KIDS. KIDS was compared to 191 industry peers in the Health Care Equipment & Supplies industry. The financial health of KIDS is average, but there are quite some concerns on its profitability. KIDS is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

KIDS had negative earnings in the past year.
In the past year KIDS has reported a negative cash flow from operations.
In the past 5 years KIDS reported 4 times negative net income.
In the past 5 years KIDS always reported negative operating cash flow.
KIDS Yearly Net Income VS EBIT VS OCF VS FCFKIDS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M -40M

1.2 Ratios

With a decent Return On Assets value of -8.29%, KIDS is doing good in the industry, outperforming 65.44% of the companies in the same industry.
KIDS has a Return On Equity of -11.75%. This is in the better half of the industry: KIDS outperforms 65.97% of its industry peers.
Industry RankSector Rank
ROA -8.29%
ROE -11.75%
ROIC N/A
ROA(3y)-4.16%
ROA(5y)-5.62%
ROE(3y)-5.3%
ROE(5y)-7.43%
ROIC(3y)N/A
ROIC(5y)N/A
KIDS Yearly ROA, ROE, ROICKIDS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

KIDS has a Gross Margin of 71.54%. This is amongst the best in the industry. KIDS outperforms 82.20% of its industry peers.
KIDS's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for KIDS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 71.54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.04%
GM growth 5Y-0.71%
KIDS Yearly Profit, Operating, Gross MarginsKIDS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

4

2. Health

2.1 Basic Checks

KIDS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for KIDS has been increased compared to 1 year ago.
KIDS has more shares outstanding than it did 5 years ago.
The debt/assets ratio for KIDS is higher compared to a year ago.
KIDS Yearly Shares OutstandingKIDS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
KIDS Yearly Total Debt VS Total AssetsKIDS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

KIDS has an Altman-Z score of 1.86. This is not the best score and indicates that KIDS is in the grey zone with still only limited risk for bankruptcy at the moment.
KIDS's Altman-Z score of 1.86 is in line compared to the rest of the industry. KIDS outperforms 57.59% of its industry peers.
KIDS has a Debt/Equity ratio of 0.27. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.27, KIDS perfoms like the industry average, outperforming 52.36% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF N/A
Altman-Z 1.86
ROIC/WACCN/A
WACC8.37%
KIDS Yearly LT Debt VS Equity VS FCFKIDS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

KIDS has a Current Ratio of 6.66. This indicates that KIDS is financially healthy and has no problem in meeting its short term obligations.
KIDS's Current ratio of 6.66 is amongst the best of the industry. KIDS outperforms 84.29% of its industry peers.
KIDS has a Quick Ratio of 3.43. This indicates that KIDS is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 3.43, KIDS is in the better half of the industry, outperforming 70.68% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 6.66
Quick Ratio 3.43
KIDS Yearly Current Assets VS Current LiabilitesKIDS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for KIDS have decreased strongly by -63.92% in the last year.
KIDS shows a strong growth in Revenue. In the last year, the Revenue has grown by 26.08%.
The Revenue has been growing by 23.04% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-63.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15.38%
Revenue 1Y (TTM)26.08%
Revenue growth 3Y27.84%
Revenue growth 5Y23.04%
Sales Q2Q%15.68%

3.2 Future

The Earnings Per Share is expected to grow by 12.84% on average over the next years. This is quite good.
The Revenue is expected to grow by 17.39% on average over the next years. This is quite good.
EPS Next Y17.4%
EPS Next 2Y12.4%
EPS Next 3Y12.84%
EPS Next 5YN/A
Revenue Next Year17.91%
Revenue Next 2Y17.51%
Revenue Next 3Y17.39%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
KIDS Yearly Revenue VS EstimatesKIDS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
KIDS Yearly EPS VS EstimatesKIDS Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.5 -1 -1.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

KIDS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for KIDS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KIDS Price Earnings VS Forward Price EarningsKIDS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KIDS Per share dataKIDS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

A more expensive valuation may be justified as KIDS's earnings are expected to grow with 12.84% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.4%
EPS Next 3Y12.84%

More info and screens

0

5. Dividend

5.1 Amount

KIDS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ORTHOPEDIATRICS CORP

NASDAQ:KIDS (10/10/2025, 8:39:59 PM)

After market: 15.52 -0.78 (-4.79%)

16.3

-1.65 (-9.19%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners71.17%
Inst Owner Change0%
Ins Owners5.07%
Ins Owner Change0.88%
Market Cap408.64M
Analysts83.08
Price Target34.53 (111.84%)
Short Float %6.69%
Short Ratio6.95
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.4%
Min EPS beat(2)-0.09%
Max EPS beat(2)2.89%
EPS beat(4)1
Avg EPS beat(4)-37.85%
Min EPS beat(4)-115.9%
Max EPS beat(4)2.89%
EPS beat(8)4
Avg EPS beat(8)-14.53%
EPS beat(12)7
Avg EPS beat(12)-2.09%
EPS beat(16)10
Avg EPS beat(16)12.68%
Revenue beat(2)0
Avg Revenue beat(2)-1.52%
Min Revenue beat(2)-2.47%
Max Revenue beat(2)-0.58%
Revenue beat(4)1
Avg Revenue beat(4)-0.57%
Min Revenue beat(4)-2.47%
Max Revenue beat(4)1.19%
Revenue beat(8)2
Avg Revenue beat(8)-0.5%
Revenue beat(12)3
Avg Revenue beat(12)-0.99%
Revenue beat(16)4
Avg Revenue beat(16)-1.21%
PT rev (1m)0%
PT rev (3m)-4.63%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-10.36%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.98%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.52%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)0.06%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.85
P/FCF N/A
P/OCF N/A
P/B 1.15
P/tB 2.32
EV/EBITDA N/A
EPS(TTM)-1.79
EYN/A
EPS(NY)-1.2
Fwd EYN/A
FCF(TTM)-1.53
FCFYN/A
OCF(TTM)-1.14
OCFYN/A
SpS8.8
BVpS14.18
TBVpS7.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.29%
ROE -11.75%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 71.54%
FCFM N/A
ROA(3y)-4.16%
ROA(5y)-5.62%
ROE(3y)-5.3%
ROE(5y)-7.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.04%
GM growth 5Y-0.71%
F-Score3
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 49.17%
Cap/Sales 4.34%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.66
Quick Ratio 3.43
Altman-Z 1.86
F-Score3
WACC8.37%
ROIC/WACCN/A
Cap/Depr(3y)87.97%
Cap/Depr(5y)110.98%
Cap/Sales(3y)9.42%
Cap/Sales(5y)12.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-63.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15.38%
EPS Next Y17.4%
EPS Next 2Y12.4%
EPS Next 3Y12.84%
EPS Next 5YN/A
Revenue 1Y (TTM)26.08%
Revenue growth 3Y27.84%
Revenue growth 5Y23.04%
Sales Q2Q%15.68%
Revenue Next Year17.91%
Revenue Next 2Y17.51%
Revenue Next 3Y17.39%
Revenue Next 5YN/A
EBIT growth 1Y-21.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year156.56%
EBIT Next 3Y50.18%
EBIT Next 5YN/A
FCF growth 1Y-22%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-41.7%
OCF growth 3YN/A
OCF growth 5YN/A